{
  "DOI": "10.1038/ejhg.2016.116",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2016.116",
  "alternative-id": [
    "BFejhg2016116"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "30 June 2016"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "5 July 2016"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "22 July 2016"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "31 August 2016"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Matthias Schwab is the contributor to patents related to TPMT. The remaining authors declare no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "van der Wouden",
      "given": "Cathelijne H",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "on behalf of the Ubiquitous-Pharmacogenomics Consortium",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Swen",
      "given": "Jesse J",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Samwald",
      "given": "Matthias",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mitropoulou",
      "given": "Christina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schwab",
      "given": "Matthias",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guchelaar",
      "given": "Henk-Jan",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        8,
        31
      ]
    ],
    "date-time": "2016-08-31T18:03:23Z",
    "timestamp": 1472666603000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:16:03Z",
    "timestamp": 1684430163000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        19
      ]
    ],
    "date-time": "2023-10-19T01:42:08Z",
    "timestamp": 1697679728505
  },
  "is-referenced-by-count": 21,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "12",
  "issued": {
    "date-parts": [
      [
        2016,
        8,
        31
      ]
    ]
  },
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2016,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            8,
            31
          ]
        ],
        "date-time": "2016-08-31T00:00:00Z",
        "timestamp": 1472601600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2016116.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2016116",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2016116.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1658-1660",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2016,
        8,
        31
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        8,
        31
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "BFejhg2016116_CR1",
      "unstructured": "Kapoor et al EJHG."
    },
    {
      "DOI": "10.1002/embr.201438641",
      "author": "K Kampourakis",
      "doi-asserted-by": "publisher",
      "first-page": "472",
      "journal-title": "EMBO Rep",
      "key": "BFejhg2016116_CR2",
      "unstructured": "Kampourakis K, Vayena E, Mitropoulou C et al: Key challenges for next-generation pharmacogenomics: science \u0026 society series on science and drugs. EMBO Rep 2014; 15: 472–476.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2013.59",
      "author": "AR Shuldiner",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR3",
      "unstructured": "Shuldiner AR, Relling MV, Peterson JF et al: The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther 2013; 94: 207–210.",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.1038/clpt.2012.117",
      "author": "PH O'Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "446",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR4",
      "unstructured": "O'Donnell PH, Bush A, Spitz J et al: The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther 2012; 92: 446–449.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ajmg.c.31385",
      "author": "PH O'Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "BFejhg2016116_CR5",
      "unstructured": "O'Donnell PH, Danahey K, Jacobs M et al: Adoption of a clinical pharmacogenomics implementation program during outpatient care—initial results of the University of Chicago \"1,200 Patients Project\". Am J Med Genet C Semin Med Genet 2014; 166C: 68–75.",
      "volume": "166C",
      "year": "2014"
    },
    {
      "DOI": "10.1136/amiajnl-2013-001993",
      "author": "GC Bell",
      "doi-asserted-by": "publisher",
      "first-page": "e93",
      "journal-title": "J Am Med Inform Assoc",
      "key": "BFejhg2016116_CR6",
      "unstructured": "Bell GC, Crews KR, Wilkinson MR et al: Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc 2014; 21: e93–e99.",
      "volume": "21",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2014.137",
      "author": "LJ Rasmussen-Torvik",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR7",
      "unstructured": "Rasmussen-Torvik LJ, Stallings SC, Gordon AS et al: Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther 2014; 96: 482–489.",
      "volume": "96",
      "year": "2014"
    },
    {
      "DOI": "10.1002/ajmg.c.31391",
      "author": "JM Hoffman",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "BFejhg2016116_CR8",
      "unstructured": "Hoffman JM, Haidar CE, Wilkinson MR et al: PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet 2014; 166C: 45–55.",
      "volume": "166C",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2013.72",
      "author": "O Gottesman",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR9",
      "unstructured": "Gottesman O, Scott SA, Ellis SB et al: The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin Pharmacol Ther 2013; 94: 214–217.",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.2217/pgs.13.59",
      "author": "JA Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "723",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg2016116_CR10",
      "unstructured": "Johnson JA, Elsey AR, Clare-Salzler MJ, Nessl D, Conlon M, Nelson DR : Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics. Pharmacogenomics 2013; 14: 723–726.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1038/clpt.2012.125",
      "author": "JA Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "437",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR11",
      "unstructured": "Johnson JA, Burkley BM, Langaee TY, Clare-Salzler MJ, Klein TE, Altman RB : Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array. Clin Pharmacol Ther 2012; 92: 437–439.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1038/clpt.2011.371",
      "author": "JM Pulley",
      "doi-asserted-by": "publisher",
      "first-page": "87",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR12",
      "unstructured": "Pulley JM, Denny JC, Peterson JF et al: Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther 2012; 92: 87–95.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.clpt.6100507",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR13",
      "unstructured": "Swen JJ, Wilting I, de Goede AL et al: Pharmacogenetics: from bench to byte. Clin Pharmacol Ther 2008; 83: 781–787.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1038/clpt.2011.34",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "662",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR14",
      "unstructured": "Swen JJ, Nijenhuis M, de Boer A et al: Pharmacogenetics: from bench to byte—an update of guidelines. Clin Pharmacol Ther 2011; 89: 662–673.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1038/clpt.2010.310",
      "author": "RB Altman",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2016116_CR15",
      "unstructured": "Altman RB : Pharmacogenomics: \"noninferiority\" is sufficient for initial implementation. Clin Pharmacol Ther 2011; 89: 348–350.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrd3921",
      "author": "M Pirmohamed",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Nat Rev Drug Discov",
      "key": "BFejhg2016116_CR16",
      "unstructured": "Pirmohamed M, Hughes DA : Pharmacogenetic tests: the need for a level playing field. Nat Rev Drug Discov 2013; 12: 3–4.",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1056/NEJMoa1311386",
      "author": "M Pirmohamed",
      "doi-asserted-by": "publisher",
      "first-page": "2294",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2016116_CR17",
      "unstructured": "Pirmohamed M, Burnside G, Eriksson N et al: A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 2013; 369: 2294–2303.",
      "volume": "369",
      "year": "2013"
    },
    {
      "DOI": "10.1056/NEJMoa1311388",
      "author": "TI Verhoef",
      "doi-asserted-by": "publisher",
      "first-page": "2304",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2016116_CR18",
      "unstructured": "Verhoef TI, Ragia G, de Boer A et al: A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med 2013; 369: 2304–2312.",
      "volume": "369",
      "year": "2013"
    },
    {
      "DOI": "10.1053/j.gastro.2015.06.002",
      "author": "MJ Coenen",
      "doi-asserted-by": "publisher",
      "first-page": "907",
      "journal-title": "Gastroenterology",
      "key": "BFejhg2016116_CR19",
      "unstructured": "Coenen MJ, de Jong DJ, van Marrewijk CJ et al: Identification of patients with variants in TPMT and dose reduction reduces hematologic events during thiopurine treatment of inflammatory bowel disease. Gastroenterology 2015; 149: 907–917.e7.",
      "volume": "149",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa0706135",
      "author": "S Mallal",
      "doi-asserted-by": "publisher",
      "first-page": "568",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2016116_CR20",
      "unstructured": "Mallal S, Phillips E, Carosi G et al: HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358: 568–579.",
      "volume": "358",
      "year": "2008"
    },
    {
      "DOI": "10.2217/pgs.14.102",
      "author": "C Mizzi",
      "doi-asserted-by": "publisher",
      "first-page": "1223",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg2016116_CR21",
      "unstructured": "Mizzi C, Peters B, Mitropoulou C et al: Personalized pharmacogenomics profiling using whole-genome sequencing. Pharmacogenomics 2014; 15: 1223–1234.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.2217/pme.13.92",
      "author": "Y Mai",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Personal Med",
      "key": "BFejhg2016116_CR22",
      "unstructured": "Mai Y, Mitropoulou C, Papadopoulou XE et al: Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Personal Med 2014; 11: 15–26.",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1159/000365896",
      "author": "C Mitropoulou",
      "doi-asserted-by": "publisher",
      "first-page": "280",
      "journal-title": "Public Health Genomics",
      "key": "BFejhg2016116_CR23",
      "unstructured": "Mitropoulou C, Mai Y, van Schaik RH, Vozikis A, Patrinos GP : Stakeholder analysis in pharmacogenomics and genomic medicine in Greece. Public Health Genomics 2014; 17: 280–286.",
      "volume": "17",
      "year": "2014"
    },
    {
      "key": "BFejhg2016116_CR24",
      "unstructured": "Bank PCD, Swen JJ, Guchelaar HJ : An evaluation of Dutch pharmacists' knowledge, experience and attitudes towards pharmacogenetic testing: results of a nation wide survey. Clin Pharmacol Ther 99 (Suppl 1): Abstracts: ASCPT 2016(abstract PII-056)."
    },
    {
      "DOI": "10.1146/annurev-pharmtox-010814-124835",
      "author": "HM Dunnenberger",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Annu Rev Pharmacol Toxicol",
      "key": "BFejhg2016116_CR25",
      "unstructured": "Dunnenberger HM, Crews KR, Hoffman JM et al: Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol 2015; 55: 89–106.",
      "volume": "55",
      "year": "2015"
    }
  ],
  "reference-count": 25,
  "references-count": 25,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2016116"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "A brighter future for the implementation of pharmacogenomic testing"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "24"
}